ABSTRACT NUMBER: ESOC2026A367 OUTCOMES OF DIRECT ENDOVASCULAR VERSUS BRIDGING THERAPY FOR ISCHEMIC STROKE DUE TO MEDIUM VESSEL OCCLUSION
Yujie MA, Liyuan Wang, Yunyun Xiong · 2026
Read ABSTRACT NUMBER: ESOC2026A367 OUTCOMES OF DIRECT ENDOVASCULAR VERSUS BRIDGING THERAPY FOR ISCHEMIC STROKE DUE TO MEDIUM VESSEL OCCLUSION by Yujie MA, Liyuan Wang, Yunyun Xiong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145625.txt.
Description
Yujie Ma, Liyuan Wang, and Yunyun Xiong compare stroke clot removal alone against clot-busting drugs first for medium vessel blockages. Their 2026 conference abstract draws on a multicenter registry of 140 patients, all treated with endovascular therapy. Recent trials in this vessel class came out neutral, leaving the drug question open.
Bridging patients, about forty of them, fare better on the ninety-day disability scale. Half reach near-full recovery versus about twenty-nine percent with removal alone. Bleeding inside the skull runs lower in the bridging group, and deaths drop from about twelve percent to none. Weighting methods balance the groups before comparison. The authors read real-world care as favoring the drug bridge, pending firmer trial proof.
Catalog record
| CREATOR | Yujie MA, Liyuan Wang, Yunyun Xiong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |